218 related articles for article (PubMed ID: 23553653)
21. Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract.
Lagos-Villaseca A; Bhatt NK; Abdolhosseini P; Quinonez L; Paoletti MF; Gochman G; Johns MM; Rosen CA; Kao TC; Meyer TK
JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):615-620. PubMed ID: 37227721
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.
Brin MF; Lyons KE; Doucette J; Adler CH; Caviness JN; Comella CL; Dubinsky RM; Friedman JH; Manyam BV; Matsumoto JY; Pullman SL; Rajput AH; Sethi KD; Tanner C; Koller WC
Neurology; 2001 Jun; 56(11):1523-8. PubMed ID: 11402109
[TBL] [Abstract][Full Text] [Related]
23. Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics.
Sinclair CF; Gurey LE; Blitzer A
Laryngoscope; 2014 May; 124(5):1164-9. PubMed ID: 24668771
[TBL] [Abstract][Full Text] [Related]
24. Voice Tremor and Botulinum Neurotoxin Therapy: A Contemporary Review.
Newland DP; Novakovic D; Richards AL
Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356023
[TBL] [Abstract][Full Text] [Related]
25. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
Young N; Blitzer A
Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
[TBL] [Abstract][Full Text] [Related]
26. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Inagi K; Rodriquez AA; Ford CN; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
[TBL] [Abstract][Full Text] [Related]
27. Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A; Pereira B; Simonetta-Moreau M; Castelnovo G; De Verdal M; Fluchère F; Laurencin C; Degos B; Tir M; Kreisler A; Blanchet-Fourcade G; Guehl D; Colin O; Poujois A; Sangla S; Tatu L; Derost P; Gayraud D; Tranchant C; Amarantini D; Devos D; Rascol O; Corvol JC; Durif F; Rieu I;
N Engl J Med; 2023 Nov; 389(19):1753-1765. PubMed ID: 37937777
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of repeated botulinum toxin injections as a function of timing.
Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
[TBL] [Abstract][Full Text] [Related]
30. [Dysport in the treatment of essential tremor].
Levin OS; Vasechkin SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):21-4. PubMed ID: 22433804
[TBL] [Abstract][Full Text] [Related]
31. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
[TBL] [Abstract][Full Text] [Related]
32. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Zesiewicz TA; Elble R; Louis ED; Hauser RA; Sullivan KL; Dewey RB; Ondo WG; Gronseth GS; Weiner WJ;
Neurology; 2005 Jun; 64(12):2008-20. PubMed ID: 15972843
[TBL] [Abstract][Full Text] [Related]
33. Transitioning from Unilateral to Bilateral Upper Limb Tremor Therapy for Parkinson's Disease and Essential Tremor Using Botulinum Toxin: Case Series.
Samotus O; Lee J; Jog M
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30262746
[TBL] [Abstract][Full Text] [Related]
34. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
Stong BC; DelGaudio JM; Hapner ER; Johns MM
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
[TBL] [Abstract][Full Text] [Related]
35. Dynamic decomposition of motion in essential and parkinsonian tremor.
Rahimi F; Debicki D; Roberts-South A; Bee C; Bapat P; Jog M
Can J Neurol Sci; 2015 Mar; 42(2):116-24. PubMed ID: 25702954
[TBL] [Abstract][Full Text] [Related]
36. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
38. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
Papapetropoulos S; Singer C
Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
[TBL] [Abstract][Full Text] [Related]
39. Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns - A New Future.
Samotus O; Rahimi F; Lee J; Jog M
PLoS One; 2016; 11(4):e0153739. PubMed ID: 27101283
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
